| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c43747bc75fc64d178ec7bf073d080cc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-60 |
| filingDate |
2017-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50430d259b5c22fb417fc20d64ce2b95 |
| publicationDate |
2018-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108997421-A |
| titleOfInvention |
A kind of antiviral drugs and its pharmaceutical composition |
| abstract |
The present invention relates to antiviral drugs and its pharmaceutical compositions, more particularly to the drug and its pharmaceutical composition of anti-human HIVvirus blood serum immunity (HIV), more particularly to a kind of drug that can be used as retroviral Protease inhibitors, which has chemical structure shown in Formulas I. |
| priorityDate |
2017-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |